Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | INVX | NWN |
|---|---|---|
| Price | $28.41 | $47.19 |
| Change today | ▲ 4.03% | ▼ 0.40% |
| Market cap | $1.99B | $1.99B |
| Return, 3 months | +18.1% | -4.3% |
| Return, year to date | +29.9% | +4.0% |
| Return, 1 year | +47.0% | +11.4% |
| P/E (TTM) | 31.9 | 15.8 |
| P/B | 1.9 | 1.3 |
| P/E percentile vs own 5y | 92nd | – |
| Dividend yield | – | 4.17% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +25.0% | +29.3% |
| Analyst buy share | 100% | 33% |
| RSI (14) | 49 | 40 |
| 30-day volatility | 39.0% | 13.6% |
| Max drawdown, 1 year | -24.0% | -14.8% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.